Loading company…
VahatiCor develops medical devices for coronary microvascular dysfunction.
Founded in 2021 and based in Santa Clara, US, VahatiCor develops the A-FLUX Reducer System® for coronary microvascular dysfunction. The system uses Swiftcell® Technology and is in investigational studies and clinical trials. As of November 2025, the company had secured USD 21.18 mn through a Series B round led by S3 Ventures, with participation from Intuitive Ventures, as part of a larger USD 32.38 million round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in